Cancer test scores $4m in capital for biotech
SYDNEY: Early-stage biotech BCAL Diagnostics has closed a $4 million pre-IPO capital raise led by
SYDNEY: Early-stage biotech BCAL Diagnostics has closed a $4 million pre-IPO capital raise led by